SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,728.16 -281.09
( -0.36%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

69,148.70 434.90
(0.63%)

Nikkei 225

10,727.81 -22.30
(-0.21%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

423.3581313

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

35.72

117138.71

EPS(TTM)

Face Value()

Div & Yield %

40.59

0.9

Back

Usha Martin consolidated net profit rises 40.67% in the June 2026 quarter

Jul 27,2026

Net profit of Usha Martin rose 40.67% to Rs 141.98 crore in the quarter ended June 2026 as against Rs 100.93 crore during the previous quarter ended June 2025. Sales rose 16.44% to Rs 1033.00 crore in the quarter ended June 2026 as against Rs 887.19 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1033.00	887.19	16
OPM %	20.14	16.30	-
PBDT	217.64	158.32	37
PBT	184.12	129.63	42
NP	141.98	100.93	41

77,728.16 -281.09 ( -0.36%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

69,148.70 434.90 (0.63%)

10,727.81 -22.30 (-0.21%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)